These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 23653350)
1. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. Balanis N; Wendt MK; Schiemann BJ; Wang Z; Schiemann WP; Carlin CR J Biol Chem; 2013 Jun; 288(25):17954-67. PubMed ID: 23653350 [TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Lo HW; Hsu SC; Xia W; Cao X; Shih JY; Wei Y; Abbruzzese JL; Hortobagyi GN; Hung MC Cancer Res; 2007 Oct; 67(19):9066-76. PubMed ID: 17909010 [TBL] [Abstract][Full Text] [Related]
3. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer. Kim MS; Lee WS; Jeong J; Kim SJ; Jin W Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594 [TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation. Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140 [TBL] [Abstract][Full Text] [Related]
5. 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling. Singh NK; Wang D; Kundumani-Sridharan V; Van Quyen D; Niu J; Rao GN J Biol Chem; 2011 Jun; 286(25):22478-88. PubMed ID: 21536676 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers. Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085 [TBL] [Abstract][Full Text] [Related]
7. The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6. Wendt MK; Williams WK; Pascuzzi PE; Balanis NG; Schiemann BJ; Carlin CR; Schiemann WP Neoplasia; 2015 Jan; 17(1):124-33. PubMed ID: 25622905 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Wendt MK; Smith JA; Schiemann WP Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523 [TBL] [Abstract][Full Text] [Related]
9. Autocrine Fibronectin Inhibits Breast Cancer Metastasis. Shinde A; Libring S; Alpsoy A; Abdullah A; Schaber JA; Solorio L; Wendt MK Mol Cancer Res; 2018 Oct; 16(10):1579-1589. PubMed ID: 29934326 [TBL] [Abstract][Full Text] [Related]
10. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling. Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151 [TBL] [Abstract][Full Text] [Related]
11. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma. Yang M; Yao P; Lang X; Li X; Zhang D Bioengineered; 2021 Dec; 12(2):12800-12811. PubMed ID: 34895038 [TBL] [Abstract][Full Text] [Related]
12. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells. Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676 [TBL] [Abstract][Full Text] [Related]
13. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells. Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways. Chen H; Pan J; Zhang L; Chen L; Qi H; Zhong M; Shi X; Du J; Li Q Eur J Pharmacol; 2018 Apr; 825():133-142. PubMed ID: 29476880 [TBL] [Abstract][Full Text] [Related]
15. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling. Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296 [TBL] [Abstract][Full Text] [Related]
16. Leptin secreted by adipocytes promotes EMT transition and endometrial cancer progression via the JAK2/STAT3 signalling pathway. Shen L; Zhang C; Cui K; Liang X; Zhu G; Hong L Adipocyte; 2024 Dec; 13(1):2293273. PubMed ID: 38090745 [TBL] [Abstract][Full Text] [Related]
17. ZnAs@SiO Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768 [No Abstract] [Full Text] [Related]
18. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin. Colomiere M; Findlay J; Ackland L; Ahmed N Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836 [TBL] [Abstract][Full Text] [Related]
19. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma. Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878 [TBL] [Abstract][Full Text] [Related]
20. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells. Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]